December 8, 2024 - 00:39

In a recent exploration of the testing methods being utilized by Robert F. Kennedy Jr. for selecting personnel for his proposed health department, a troubling picture emerged. The assessment in question is designed to evaluate candidates' beliefs and ideologies regarding health and wellness, but it raises significant concerns about its implications for public health policy.
Participants reported feeling as though their critical thinking abilities were compromised, likening the experience to having their brains consumed by a metaphorical worm. This unsettling analogy highlights the potential dangers of prioritizing ideology over evidence-based science in health-related decision-making.
The test appears to prioritize conformity to specific beliefs rather than a diverse range of perspectives, which is essential in addressing complex public health issues. Critics argue that such an approach could lead to a narrow-minded view of health policy, undermining the integrity of public health initiatives. As the health landscape continues to evolve, the need for inclusive and scientifically grounded approaches has never been more crucial.
July 23, 2026 - 15:06
Good riddance to bundled ‘global’ maternal care billingThe American College of Obstetricians and Gynecologists is welcoming a major shift in how pregnancy and childbirth are billed. For years, the system relied on a single, bundled `global` fee that...
July 22, 2026 - 21:50
West Nile virus found in two mosquito traps in DeKalb County, health officials sayHealth authorities in DeKalb County have confirmed that mosquitoes collected from two separate traps have tested positive for the West Nile virus. The positive samples were identified during...
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...